A detailed history of Frederick Financial Consultants, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Frederick Financial Consultants, LLC holds 2,709 shares of ABBV stock, worth $633,906. This represents 0.35% of its overall portfolio holdings.

Number of Shares
2,709
Previous 2,641 2.57%
Holding current value
$633,906
Previous $490 Million 27.94%
% of portfolio
0.35%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$184.85 - $231.54 $12,569 - $15,744
68 Added 2.57%
2,709 $627 Million
Q2 2025

Aug 04, 2025

BUY
$170.16 - $206.27 $20,419 - $24,752
120 Added 4.76%
2,641 $490 Million
Q1 2025

May 02, 2025

BUY
$169.2 - $216.66 $112,856 - $144,512
667 Added 35.98%
2,521 $528 Million
Q4 2024

Feb 13, 2025

BUY
$164.99 - $203.87 $305,891 - $377,974
1,854 New
1,854 $329 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Frederick Financial Consultants, LLC Portfolio

Follow Frederick Financial Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frederick Financial Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frederick Financial Consultants, LLC with notifications on news.